Status:
COMPLETED
Local Anesthetic Treatment of Oral Pain in Patients With Mucositis
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Moberg Pharma, Sweden
Conditions:
Mucositis
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Oral mucositis is a damage to the mucosa of the oral cavity and pharynx. It is a serious and painful adverse effect caused by the radio therapy and/or chemo therapy patients with head and neck cancer ...
Eligibility Criteria
Inclusion
- diagnosed with head/neck cancer and starting radio therapy treatment
- age between 18 and 80 years (both included)
- able to talk, read and understand Danish
- ability to give informed consent
Exclusion
- known hypersensitivity towards bupivacaine or other local anesthetics of the amide type
- pregnancy
- women breastfeeding a child
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT02252926
Start Date
September 1 2014
End Date
December 1 2015
Last Update
August 16 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Oncology, Rigshospitalet
Copenhagen, Denmark, 2100
2
Department of Oncology, Herlev Hospital, Denmark
Herlev, Denmark, 2730